Valuation: SK Biopharmaceuticals Co., Ltd.

Capitalization 8,591B 5.9B 5.73B 5.39B 4.84B 8.5B 511B 9.5B 65.87B 24.4B 210B 22.13B 21.67B 922B P/E ratio 2024 *
129x
P/E ratio 2025 * 57.4x
Enterprise value 8.45B 5.81M 5.64M 5.31M 4.76M 8.36M 503M 9.34M 64.82M 24.01M 206M 21.77M 21.33M 907M EV / Sales 2024 *
15.9x
EV / Sales 2025 * 12.2x
Free-Float
35.81%
Yield 2024 *
-
Yield 2025 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day-2.58%
1 week-6.32%
Current month-1.26%
1 month+4.18%
3 months-12.73%
6 months+34.11%
Current year-1.26%
More quotes
1 week
108 500.00
Extreme 108500
116 700.00
1 month
99 700.00
Extreme 99700
118 700.00
Current year
105 900.00
Extreme 105900
118 700.00
1 year
72 600.00
Extreme 72600
130 000.00
3 years
50 900.00
Extreme 50900
130 000.00
5 years
50 900.00
Extreme 50900
269 500.00
10 years
50 900.00
Extreme 50900
269 500.00
More quotes
Director TitleAgeSince
Chief Executive Officer 57 2022-12-31
Director of Finance/CFO 52 -
Manager TitleAgeSince
Director/Board Member 68 2019-08-26
Director/Board Member 55 2019-08-26
Director/Board Member 53 2023-03-27
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
-2.58%-6.32%+16.08%+19.50%6.05B
-1.40%-0.46%-3.58%-26.05%64.16B
+0.11%-1.51%-5.79%-22.23%7.48B
-1.03%+3.79%+52.05%+60.56%7.04B
-1.47%+0.75%+115.43%+142.19%6.99B
+5.13%+7.87%+20.91%-26.96%3.04B
-0.34%+0.67%+35.22%+29.03%2.09B
+1.50%+3.42%+24.24%+9.02%2.07B
-0.31%+5.22%-39.96%+1.27%1.68B
-.--%-.--% - - 1.64B
Average -0.02%+0.18%+23.85%+20.70% 10.22B
Weighted average by Cap. -0.94%+0.43%+11.11%-2.98%
See all sector performances

Financials

2024 *2025 *
Net sales 533B 366M 356M 334M 300M 527M 31.68B 589M 4.08B 1.51B 13.01B 1.37B 1.34B 57.19B 685B 470M 457M 430M 386M 677M 40.72B 757M 5.25B 1.94B 16.72B 1.76B 1.73B 73.5B
Net income 65.39B 44.91M 43.64M 41.06M 36.84M 64.7M 3.89B 72.28M 501M 186M 1.6B 168M 165M 7.02B 138B 94.8M 92.12M 86.66M 77.76M 137M 8.21B 153M 1.06B 392M 3.37B 356M 348M 14.82B
Net Debt -137B -94.4M -91.72M -86.29M -77.43M -136M -8.17B -152M -1.05B -390M -3.36B -354M -347M -14.75B -249B -171M -166M -156M -140M -246M -14.79B -275M -1.91B -706M -6.07B -640M -627M -26.69B
More financial data * Estimated data
Logo SK Biopharmaceuticals Co., Ltd.
SK Biopharmaceuticals Co Ltd is a Korea-based company mainly engages in the development and manufacture of pharmaceuticals. The Company mainly develops and produces pharmaceuticals including epilepsy drugs, sleep disorder drugs, rare neurological disorder drugs, concentration disorder drugs, schizophrenia drugs, and bipolar disorder drugs, among others. The Company also engages in the new drug development business.
Employees
241
More about the company
Date Price Change Volume
25-01-16 109,700.00 -2.58% 239,922
25-01-16 112,600.00 +2.09% 267,622
25-01-15 110,300.00 -0.54% 184,331
25-01-14 110,900.00 -3.73% 242,519
25-01-13 115,200.00 +0.09% 192,514

End-of-day quote Korea S.E., January 16, 2025

More quotes
Trading Rating
Investor Rating
ESG MSCI
AAA
surperformance-ratings-light-chart SK-BIOPHARMACEUTICALS-CO-More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
109,700.00KRW
Average target price
123,642.86KRW
Spread / Average Target
+12.71%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A326030 Stock